Fikes; John D.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Fikes; John D..The latest application filed is for "hla-dr binding peptides and their uses".

Company Profile

2.10.22

Fikes; John D. - San Diego CA
Fikes; John D. - Utrecht NL
Fikes, John D - San Diego CA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
HLA-DR binding peptides and their uses Grant 10,556,943 - Knutson , et al. Feb	2020-02-11
HLA-A2 tumor associated antigen peptides and compositions Grant 9,913,884 - Fikes , et al. March 13, 2	2018-03-13
Hla-dr Binding Peptides And Their Uses App 20170342126 - Knutson; Keith L. ; et al.	2017-11-30
Hla-a2 Tumor Associated Antigen Peptides And Compositions App 20170028041 - Fikes; John D. ; et al.	2017-02-02
HLA-A2 tumor associated antigen peptides and compositions Grant 9,394,350 - Fikes , et al. July 19, 2	2016-07-19
Hla-dr Binding Peptides And Their Uses App 20140377340 - Knutson; Keith L. ; et al.	2014-12-25
Heteroclitic analogs and related methods Grant 8,741,576 - Tangri , et al. June 3, 2	2014-06-03
Hla Class I A2 Tumor Associated Antigen Peptides And Vaccine Compositions App 20140147490 - Fikes; John D. ; et al.	2014-05-29
Hla-a2 Tumor Associated Antigen Peptides And Compositions App 20140141064 - FIKES; JOHN D. ; et al.	2014-05-22
Hla-a2 Tumor Associated Antigen Peptides And Compositions App 20120183598 - Fikes; John D. ; et al.	2012-07-19
Hla Class I A2 Tumor Associated Antigen Peptides And Vaccine Compositions App 20110318408 - Fikes; John D. ; et al.	2011-12-29
HLA-A2 tumor associated antigen peptides and compositions Grant 8,007,810 - Fikes , et al. August 30, 2	2011-08-30
Hla-dr Binding Peptides And Their Uses App 20100310640 - Knutson; Keith L. ; et al.	2010-12-09
HLA-A2 Tumor Associated Antigen Peptides and Compositions App 20100209493 - FIKES; John D. ; et al.	2010-08-19
Heteroclitic analogs and related methods App 20090169574 - Tangri; Shabnam ; et al.	2009-07-02
HLA class I A2 tumor associated antigen peptides and vaccine compositions App 20080279924 - Fikes; John D. ; et al.	2008-11-13
Hla-A2 Tumor Associated Antigen Peptides and Compositions App 20080274129 - Fikes; John D. ; et al.	2008-11-06
HLA class I A2 tumor associated antigen peptides and vaccine compositions App 20070098776 - Fikes; John D. ; et al.	2007-05-03
Hla-a1,-a2,-a3,-a24,-b7, and-b44 tumor associated antigen peptides and compositions App 20060094649 - Keogh; Elissa A. ; et al.	2006-05-04
Hla class I a2 tumor associated antigen peptides and vaccine compositions App 20030224036 - Fikes, John D ; et al.	2003-12-04
Expression vectors for stimulating an immune response and methods of using the same App 20030220285 - Fikes, John D. ; et al.	2003-11-27
Expression vectors for stimulating an immune response and methods of using the same App 20030216343 - Fikes, John D. ; et al.	2003-11-20
Expression vectors for stimulating an immune response and methods of using the same App 20030216342 - Fikes, John D. ; et al.	2003-11-20
Expression vectors for stimulating an immune response and methods of using the same App 20030203869 - Fikes, John D. ; et al.	2003-10-30
HLA class I A2 tumor associated antigen peptides and vaccine compositions Grant 6,602,510 - Fikes , et al. August 5, 2	2003-08-05
Heteroclitic analogs and related methods App 20030143672 - Tangri, Shabnam ; et al.	2003-07-31
Expression vectors for stimulating an immune response and methods of using the same Grant 6,534,482 - Fikes , et al. March 18, 2	2003-03-18
DNA encoding MAGE-1 C-terminal cytotoxic t lymphocyte immunogenic peptides Grant 5,750,395 - Fikes , et al. May 12, 1	1998-05-12

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.